The mission of the Small Molecule Biomarker Core (SMBC) is to facilitate researchers’ efforts to improve health via the quantitative analysis of small molecules.
The SMBC provides accurate and sensitive quantitative analysis in biological samples using state-of-the-art ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). It offers comprehensive assay development and validation according to FDA bioanalytical guidelines and sample analysis (with or without sample processing). Analytical methods include numerous small molecule drug and metabolite panels such as antiretrovirals (eg, lenacapavir), endocrine markers (eg, estrogens), metformin, sildenafil, trimethylamine N-oxide (TMAO), and tetrahydrocannabinol (THC). A full list of methods with sample type can be found here.
Primary Sq. Ft: 419
|
Days of the Week |
Hours open |
|
Monday – Friday |
8:00 am – 4:00 pm |
| Name | Role | Phone | Location | |
|---|---|---|---|---|
| Raymond West, PhD |
Assistant Director (Facility Director)
|
412-648-9854
|
rew82@pitt.edu
|
223 Salk Pavilion
|
| Thomas Nolin, PharmD, PhD |
Faculty Director
|
nolin@pitt.edu
|
206 Salk Pavilion
|
|
| SMBC General email |
biomarkers@pitt.edu
|
223 Salk Pavilion
|
||
| Patrick Oberly |
Core Staff
|
pjo7@pitt.edu
|
223 Salk Pavilion
|